IRIS Accounts Production v24.3.2.46 09563106 Board of Directors 1.4.23 31.3.24 31.3.24 0 0 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh095631062023-03-31095631062024-03-31095631062023-04-012024-03-31095631062022-03-31095631062022-04-012023-03-31095631062023-03-3109563106ns15:EnglandWales2023-04-012024-03-3109563106ns14:PoundSterling2023-04-012024-03-3109563106ns10:Director12023-04-012024-03-3109563106ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3109563106ns10:SmallEntities2023-04-012024-03-3109563106ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3109563106ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3109563106ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3109563106ns10:FullAccounts2023-04-012024-03-3109563106ns10:OrdinaryShareClass12023-04-012024-03-3109563106ns10:Director22023-04-012024-03-3109563106ns10:Director32023-04-012024-03-3109563106ns10:Director42023-04-012024-03-3109563106ns10:RegisteredOffice2023-04-012024-03-3109563106ns5:CurrentFinancialInstruments2024-03-3109563106ns5:CurrentFinancialInstruments2023-03-3109563106ns5:Non-currentFinancialInstruments2024-03-3109563106ns5:Non-currentFinancialInstruments2023-03-3109563106ns5:ShareCapital2024-03-3109563106ns5:ShareCapital2023-03-3109563106ns5:RetainedEarningsAccumulatedLosses2024-03-3109563106ns5:RetainedEarningsAccumulatedLosses2023-03-3109563106ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3109563106ns5:WithinOneYearns5:CurrentFinancialInstruments2023-03-3109563106ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-03-3109563106ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-03-3109563106ns10:OrdinaryShareClass12024-03-3109563106ns5:RetainedEarningsAccumulatedLosses2023-03-3109563106ns5:RetainedEarningsAccumulatedLosses2023-04-012024-03-31
REGISTERED NUMBER: 09563106 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 March 2024

for

Nargistame Limited

Nargistame Limited (Registered number: 09563106)






Contents of the Financial Statements
for the Year Ended 31 March 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Nargistame Limited

Company Information
for the Year Ended 31 March 2024







DIRECTORS: Mrs C Allen
B G Eades
V Bhargava
S Virmani





REGISTERED OFFICE: Universal Square
Building 2, 3rd Floor
Devonshire Street North
Manchester
M12 6JH





REGISTERED NUMBER: 09563106 (England and Wales)





ACCOUNTANTS: Uppal & Warr
Chartered Accountants
452 Manchester Road
Heaton Chapel
Stockport
SK4 5DL

Nargistame Limited (Registered number: 09563106)

Balance Sheet
31 March 2024

31.3.24 31.3.23
Notes £    £   
CURRENT ASSETS
Stocks 4 2,716,220 2,716,220
Debtors 5 1,181,279 1,110,705
Cash at bank 5,423 -
3,902,922 3,826,925
CREDITORS
Amounts falling due within one year 6 1,017,827 1,005,844
NET CURRENT ASSETS 2,885,095 2,821,081
TOTAL ASSETS LESS CURRENT
LIABILITIES

2,885,095

2,821,081

CREDITORS
Amounts falling due after more than one
year

7

2,220,595

2,469,005
NET ASSETS 664,500 352,076

CAPITAL AND RESERVES
Called up share capital 8 100 100
Retained earnings 9 664,400 351,976
SHAREHOLDERS' FUNDS 664,500 352,076

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 25 October 2024 and were signed on its behalf by:



Mrs C Allen - Director


Nargistame Limited (Registered number: 09563106)

Notes to the Financial Statements
for the Year Ended 31 March 2024

1. STATUTORY INFORMATION

Nargistame Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. STOCKS
31.3.24 31.3.23
£    £   
Stocks 2,716,220 2,716,220

Nargistame Limited (Registered number: 09563106)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Trade debtors 35,184 78,032
Other debtors 613,053 501,883
Associated company loans 490,593 460,799
Accruals and prepayments 42,449 69,991
1,181,279 1,110,705

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Bank loans and overdrafts - 57,278
Trade creditors 112,380 169,425
Tax 163,607 68,577
VAT 27,618 16,754
Other creditors 185,754 204,818
Associated company loans - 15,541
Accruals and deferred income 528,468 473,451
1,017,827 1,005,844

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.3.24 31.3.23
£    £   
Bank loans 2,220,595 2,469,005

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.24 31.3.23
value: £    £   
100 Ordinary £1 100 100

9. RESERVES
Retained
earnings
£   

At 1 April 2023 351,976
Profit for the year 312,424
At 31 March 2024 664,400